Our top pick for
Ra Medical Systems, Inc is a medical devices business based in the US. Ra Medical Systems shares (RMED) are listed on the NYSE and all prices are listed in US Dollars. Ra Medical Systems employs 85 staff and has a trailing 12-month revenue of around USD$4.6 million.
|Latest market close||USD$6.33|
|52-week range||USD$4.25 - USD$67.1975|
|50-day moving average||USD$5.6131|
|200-day moving average||USD$8.5686|
|Wall St. target price||USD$16|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-4.109|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||-4.95%|
|1 month (2020-12-15)||-12.45%|
|3 months (2020-10-15)||2,312.35%|
|6 months (2020-07-15)||1,339.29%|
|1 year (2020-01-15)||211.82%|
|2 years (2019-01-15)||-34.88%|
|3 years (2018-01-12)||N/A|
|5 years (2016-01-12)||N/A|
|Revenue TTM||USD$4.6 million|
|Gross profit TTM||USD$-1,651,000|
|Return on assets TTM||-45.55%|
|Return on equity TTM||-97.8%|
|Market capitalisation||USD$18.1 million|
TTM: trailing 12 months
There are currently 26,398 Ra Medical Systems shares held short by investors – that's known as Ra Medical Systems's "short interest". This figure is 67% down from 80,098 last month.
There are a few different ways that this level of interest in shorting Ra Medical Systems shares can be evaluated.
Ra Medical Systems's "short interest ratio" (SIR) is the quantity of Ra Medical Systems shares currently shorted divided by the average quantity of Ra Medical Systems shares traded daily (recently around 87993.333333333). Ra Medical Systems's SIR currently stands at 0.3. In other words for every 100,000 Ra Medical Systems shares traded daily on the market, roughly 300 shares are currently held short.
However Ra Medical Systems's short interest can also be evaluated against the total number of Ra Medical Systems shares, or, against the total number of tradable Ra Medical Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ra Medical Systems's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Ra Medical Systems shares in existence, roughly 10 shares are currently held short) or 0.0091% of the tradable shares (for every 100,000 tradable Ra Medical Systems shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ra Medical Systems.
Find out more about how you can short Ra Medical Systems stock.
We're not expecting Ra Medical Systems to pay a dividend over the next 12 months.
Ra Medical Systems's shares were split on a 1:25 basis on 17 November 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ra Medical Systems shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Ra Medical Systems shares which in turn could have impacted Ra Medical Systems's share price.
Over the last 12 months, Ra Medical Systems's shares have ranged in value from as little as $4.25 up to $67.1975. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ra Medical Systems's is 1.5449. This would suggest that Ra Medical Systems's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.